C07D 487/14
Ortho-condensed systems
C07D487/14 (Ortho-condensed systems) appears on 1,316 US grants and 1,431 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,316
- Published applications
- 1,431
- Assignees
- 645
- Inventors
- 4,066
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 7 | 0 |
| 1978 | 10 | 0 |
| 1979 | 5 | 0 |
| 1980 | 9 | 0 |
| 1981 | 11 | 0 |
| 1982 | 27 | 0 |
| 1983 | 18 | 0 |
| 1984 | 11 | 0 |
| 1985 | 2 | 0 |
| 1986 | 13 | 0 |
| 1987 | 13 | 0 |
| 1988 | 16 | 0 |
| 1989 | 18 | 0 |
| 1990 | 5 | 0 |
| 1991 | 12 | 0 |
| 1992 | 19 | 0 |
| 1993 | 19 | 0 |
| 1994 | 10 | 0 |
| 1995 | 17 | 0 |
| 1996 | 18 | 0 |
| 1997 | 22 | 0 |
| 1998 | 15 | 0 |
| 1999 | 13 | 0 |
| 2000 | 8 | 0 |
| 2001 | 10 | 3 |
| 2002 | 13 | 9 |
| 2003 | 10 | 28 |
| 2004 | 8 | 24 |
| 2005 | 17 | 27 |
| 2006 | 25 | 33 |
| 2007 | 20 | 35 |
| 2008 | 19 | 19 |
| 2009 | 25 | 36 |
| 2010 | 18 | 31 |
| 2011 | 24 | 49 |
| 2012 | 32 | 59 |
| 2013 | 43 | 53 |
| 2014 | 46 | 74 |
| 2015 | 58 | 78 |
| 2016 | 66 | 87 |
| 2017 | 74 | 81 |
| 2018 | 68 | 64 |
| 2019 | 57 | 68 |
| 2020 | 41 | 78 |
| 2021 | 45 | 87 |
| 2022 | 57 | 96 |
| 2023 | 56 | 123 |
| 2024 | 70 | 88 |
| 2025 | 63 | 65 |
| 2026 | 28 | 36 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds comprising a linker for increasing transcyclooctene stability25 Aug 2026US 12,714,752 B2Tagworks Pharmaceuticals B.V.
- Method for preparing 3,6-diaminopyrazine-2,5-dicarboxylic acid and synthetic intermediate thereof28 Jul 2026US 12,692,240 B2MediBeacon Inc.
- Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents28 Jul 2026US 12,692,267 B2Madera Therapeutics, LLC
- Tricyclic triazolo compounds as DGK inhibitors28 Jul 2026US 12,692,276 B2Incyte Corporation
- Cyclic azine compound, material for organic light emitting diode, electron transport material for organic light emitting diode, and organic light emitting diode14 Jul 2026US 12,679,821 B2Sagami Chemical Research Institute
- Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof8 Oct 2026US 2026/0308162 A1
- Compositions, methods, and kits related to modulation of zinc transporter zip121 Oct 2026US 2026/0294887 A1West Virginia University Board of Governors on behalf of West Virginia University
- Processes for the preparation of (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof1 Oct 2026US 2026/0297101 A1
- Inhibitors of parg24 Sep 2026US 2026/0285875 A1858 Therapeutics, Inc.
- Cyclic compounds for organic electroluminescent devices24 Sep 2026US 2026/0293520 A1UDC Ireland Limited
Most cited
By later US patents
- Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders107US 7,622,451 B2University of Kansas · 2009
- Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors97US 5,990,109 ABristol-Myers Squibb Company · 1999
- Organic compounds96US 8,633,180 B2Intra-Cellular Therapies, Inc. · 2014
- Organic compounds95US 8,664,207 B2Intra-Cellular Therapies, Inc. · 2014
- Organic compounds93US 8,536,159 B2Intra-Cellular Therapies, Inc. · 2013